|
Market Closed -
NYSE
04:00:02 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 324.35 USD | -0.31% |
|
-5.51% | -3.97% |
| Oct. 21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| Oct. 21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 61.89B 55.5B 51.23B 46.46B 86.58B 5,893B 87.83B 613B 244B 3,084B 232B 227B 9,764B | P/E 2026 * |
17.8x | P/E 2027 * | 19.6x |
|---|---|---|---|---|---|
| Enterprise Value | 69.33B 62.17B 57.38B 52.04B 96.99B 6,601B 98.38B 687B 274B 3,455B 260B 255B 10,938B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.19x |
| Free-Float |
61.21% | Yield 2026 * |
0.73% | Yield 2027 * | 0.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Xetra
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | -0.31% | ||
| 1 week | -5.51% | ||
| Current month | +8.03% | ||
| 1 month | +5.68% | ||
| 3 months | +4.24% | ||
| 6 months | +4.58% | ||
| Current year | -3.97% |
| 1 week | 320.06 |  | 344.43 |
| 1 month | 295.01 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 182.75 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.7 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Other | Director | 275 | 0.0001% | ||
| 10/1/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 10/1/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | -5.51% | -3.48% | +72.86% | 62.09B | |
| -0.45% | +0.19% | -19.30% | +10.54% | 178B | |
| +0.86% | -0.13% | -20.78% | +16.07% | 116B | |
| +0.88% | +0.16% | +0.69% | +36.51% | 115B | |
| -2.26% | +18.07% | -43.85% | +5.76% | 93.1B | |
| +0.17% | +1.64% | +8.50% | +82.24% | 55.87B | |
| +0.07% | +0.70% | +4.34% | -22.43% | 53.12B | |
| +0.30% | +0.89% | -13.05% | +43.83% | 44.22B | |
| +0.10% | +3.37% | -4.73% | -8.71% | 33.59B | |
| +0.08% | -8.30% | +11.31% | -11.95% | 29.65B | |
| Average | -0.06% | +1.21% | -8.03% | +22.47% | 78.07B | |
| Weighted average by Cap. | -0.10% | +1.96% | -12.50% | +22.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 302B 279B 253B 471B 32,089B 478B 3,338B 1,330B 16,794B 1,264B 1,238B 53,170B | 352B 315B 291B 264B 492B 33,484B 499B 3,483B 1,388B 17,524B 1,319B 1,292B 55,481B |
| Net income | 3.58B 3.21B 2.96B 2.69B 5.01B 341B 5.08B 35.46B 14.13B 178B 13.43B 13.15B 565B | 2.84B 2.55B 2.35B 2.14B 3.98B 271B 4.04B 28.18B 11.23B 142B 10.67B 10.45B 449B |
| Net Debt | 7.44B 6.67B 6.16B 5.58B 10.4B 708B 10.55B 73.67B 29.35B 371B 27.9B 27.32B 1,173B | 5.95B 5.33B 4.92B 4.46B 8.32B 566B 8.44B 58.9B 23.47B 296B 22.31B 21.84B 938B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | $324.35 | -0.31% | 1,062,303 |
| 26-10-27 | $325.37 | -1.40% | 1,123,060 |
| 26-10-26 | $330.00 | -0.30% | 993,480 |
| 26-10-23 | $331.00 | -2.21% | 1,168,293 |
| 26-10-22 | $338.48 | -0.57% | 1,183,276 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
